Adhera Therapeutics, Inc. Convertible Notes Payable
Adhera Therapeutics, Inc. had Convertible Notes Payable of $1.17 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2023-11-20
- 2023-09-30: Convertible Notes Payable $1.17M.
- 2023-06-30: Convertible Notes Payable $1.18M.
- 2023-03-31: Convertible Notes Payable $1.23M.
- 2022-12-31: Convertible Notes Payable $1.32M; Convertible Notes Payable as first filed $1.32M.
| Period end | Convertible Notes Payable | Convertible Notes Payable as first filed |
|---|---|---|
| 2023-09-30 | $1.17M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $1.18M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $1.23M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $1.32M 10-Q · filed 2023-11-20 | $1.32M 10-K · filed 2023-03-31 |
| 2022-09-30 | $1.30M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.43M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.76M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.52M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.30M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $906.00K 10-Q · filed 2021-08-23 | |
| 2020-12-31 | $720.00K 10-K · filed 2022-04-15 |